Christopher Reynolds, PhD, Scientist, Myriad Genetics
Christopher Reynolds, Ph.D., is a scientist at Myriad Genetics, where he contributes to the development, research, and production support of Precise Tumor and other precision oncology products. His current work focuses on advancing liquid biopsy approaches for next-generation sequencing (NGS) in cancer testing. He earned his doctorate in chemistry from Penn State, with prior research experience in analytical biochemistry.
